Business
Telescope Innovations Appoints Vaso Vlachos as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, is pleased to announce the appointment of Vaso Vlachos as Chief Operating Officer (COO), effective immediately.Ms. Vlachos is a proven leader with over 20 years of experience managing automation and analytical...
About this update from Telescope Innovations Corp
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - September 2, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, is pleased to announce the appointment of Vaso Vlachos as Chief Operating Officer (COO), effective immediately.","length":430,"tagName":"p"},{"type":"text","content":"Ms. Vlachos is a proven leader with over 20 years of experience managing automation and analytical technology offerings for the biopharmaceutical and chemical industries. Her background spans sales & marketing, operations, quality, and innovation management. Most recently, she was the Global Head of Mettler-Toledo AutoChem's Real-Time Analytics ("RTA") business. She also previously steered the market development and commercialization of Mettler-Toledo's EasySampler™ probe, which has achieved long-lived, multi-year adoption by the pharmaceutical industry, integration with major lab instrument partners, and successfully developed and maintained a global distribution a decade after its launch. The EasySampler probe is also a key component of Telescope's DirectInject-LC™ product.","length":812,"tagName":"p"},{"type":"text","content":"POSITIONING TO SCALE TELESCOPE'S ONLINE ANALYTICS BUSINESS","length":62,"tagName":"p"},{"type":"text","content":"Telescope's first commercial product, DirectInject-LC™ has doubled in sales opportunities in its third fiscal quarter of 2025 compared to Q3, 2024, and commercial operations have expanded from the US and Canada to Europe, Japan, and China. Ms. Vlachos' experience in global product integration with sales and services strengthens Telescope's ability to grow both its installation base and bolster recurring revenue streams.","length":435,"tagName":"p"},{"type":"text","content":"EXPANDING OPPORTUNITES IN SELF-DRIVING LABS","length":43,"tagName":"p"},{"type":"text","content":"Beyond DirectInject-LC™, Telescope is advancing Self-Driving Lab ("SDL") deployments with leading partners, including Pfizer. Ms. Vlachos' track record aligning product, software, and field organizations will support efficient delivery and lifecycle management as SDL programs move from pilots to...